Delayed Tolerance Through Mixed Chimerism (clinicaltrials.gov) - Sep 29, 2026 - P1/2 | N=20 | Recruiting | Sponsor: Massachusetts General Hospital | Active, not recruiting ➔ Recruiting | Trial completion date: Dec 2030 ➔ Dec 2032 | Trial primary completion date: Dec 2028 ➔ Dec 2031
Enrollment open • Trial completion date • Trial primary completion date • Renal Disease • Transplantation • CD34
|